Biological Psychiatry Study Shows Speech-Latency Vocal Biomarker Can Strengthen Drug–Placebo Separation in Schizophrenia Trials February 26, 2026 Read more
Clario leads the way in responsible artificial intelligence with ISO 42001 certification, audited by Schellman February 18, 2026 Read more
Thermo Fisher Scientific to Acquire Clario, Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights October 29, 2025 Read more